CD BioGlyco, a leading provider of glycobiology research services, is proud to announce the release of its advanced glycogenomics platform. This platform integrates cutting-edge technologies and expertise to provide comprehensive solutions for glycogene editing, expression profiling, and disease-related research.
Glycogenomics is a rapidly evolving field that combines genomics and glycomics to study the complex networks of glycans and glycan-protein interactions. With over 180 identified human glycogenes, these genes involved in glycan synthesis play critical roles in various biological processes and diseases. CD BioGlyco’s glycogenomics platform is designed to support researchers in deciphering the functions of these glycogenes and discovering new biomarkers and therapeutic targets.
The platform offers a range of services, including precise glycogene editing technologies, efficient delivery systems, and advanced expression profiling. Researchers can leverage these services to gain insights into glycan-protein linkages, understand how glycogenes influence glycosylation patterns, and identify potential disease biomarkers. The platform is particularly valuable for cancer research, where aberrant glycosylation is known to contribute to tumorigenesis and metastasis.
“We are excited to provide this advanced platform for the glycogenomics community,” said Anna, one of the representative speakers from CD BioGlyco. “Our goal is to support researchers in pushing the boundaries of glycogenomics and translating discoveries into improvements in human health. With our expertise and tailored services, we aim to accelerate breakthroughs in this rapidly evolving field.”
CD BioGlyco‘s glycogenomics platform has already gained international recognition for its quality and versatility. The company’s experienced team works closely with clients to design customized experimental approaches that meet their specific research needs.
To learn more about CD BioGlyco’s glycogenomics platform and how it can support your research, please visit https://www.bioglyco.com/glycogenomics-platform.html.
About CD BioGlyco
CD BioGlyco is a leading provider of glycobiology research services. With extensive expertise in glycogenomics, the company offers a range of platforms and services to support researchers in advancing our understanding of glycan biology and its role in human health and disease. CD BioGlyco is committed to delivering high-quality services and contributing to breakthroughs in the glycobiology field.